2 results
Approved WMOCompleted
To determine the safety and tolerability of L19-IL2 combined with SABR.
Approved WMOCompleted
Primary:The primary objective of this study is to demonstrate that the overall progression-free survival (PFS) of 8 cycles of intermittent (2 times 4 cycles) chemotherapy (paclitaxel) is not inferior in efficacy, compared to 8 continuous cycles of…